Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (13)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (1)
Events (2)
- Next Events (1)
- Past Events (1)
Guidance (143)
- Administering (10)
- Dosing (2)
- Implementation (12)
- Medication Safety (1)
- Patient Group Directions (143)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (80)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (2)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (1)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Medicines planning (22)
- Patient Group Direction Planning (22)
Publications (96)
- Explainer videos (4)
- Research and audits (3)
- Summary advice (10)
- Templates (79)
Specialty (71)
- Infection and infectious diseases (26)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (12)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (12)
- Skin disorders (10)
- Smoking cessation (2)
- Vaccinating (3)
Training and Development (6)

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Repeat supply or administration of medicines under PGD

26 April 2021Patient Group Directions are not an appropriate mechanism for regular repeated supplies or administration of a medicine. Prescribing is preferred.

Extension of expiry date of a Patient Group Direction

26 April 2021This article advises on the extension to the expiry date of a PGD where a full review and re-authorisation has not taken place.

Patient Group Directions in Complex Commissioning Scenarios

10 June 2021This guide supports planning, decision making and advises on governance processes when PGDs are used within commissioned services.

Retaining legal mechanism documentation

10 June 2021Advice on the retention of all records relating to legal mechanisms, such as PSDs, PGDs, Written Instructions and National Protocols

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Lidocaine injection for subdermal etonogestrel in contraception

4 October 2021SPS PGD template for administering lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implants.

Etonogestrel (e.g. Nexplanon®) implant for contraception

4 October 2021SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.

Implementing the National Patient Group Direction (PGD) Templates

4 October 2021SPS national PGD templates can be implemented by organisations to improve consistency and reduce duplication of effort.

Levonorgestrel 1500 microgram tablets for emergency contraception

4 October 2021SPS PGD template for the supply and/or administration of levonorgestrel 1500 microgram tablets for emergency contraception.

SPS - Specialist Pharmacy Service

NHS